– USA, FL – Spirion, a pioneer in sensitive data governance, today announced the appointments of Marshall Heilman and Pieter De Leenheer (Ph.D.) to its Board of Directors, effective immediately.
“Marshall’s deep experience in sensitive data threat intelligence and Pieter’s record of impactful data innovation make them ideally suited to join our board. Their demonstrated leadership in high-growth cybersecurity and data governance organizations of significant scale will bring valuable expertise and perspective through our next phase of company growth,” said CEO, Kevin Coppins.
About Marshall Heilman
Marshall Heilman is CTO at Mandiant. He brings more than 20 years of cybersecurity, engineering, and executive leadership experience to Spirion’s board. During his 16-year tenure at Mandiant, Heilman developed and led globally recognized consulting and advanced threat intelligence research capabilities—including high-performing threat research, system development, and malware analysis teams; managed detection and response business; and global Incident Response and Red Team operations. Before Mandiant, he served in the United States Marine Corps where he specialized in networking and information security operations.
Marshall Heilman holds an MBA from Arizona State University and a B.S. degree in computer information systems from the University of Maryland Global Campus and advises pre-IPO stage companies and venture capital firms.
“I’m excited to bring my experience mitigating some of the world’s most impactful security breaches to Spirion’s board in support of their worthy mission of helping organizations defend against impact from persistent cyber threats,” commented Marshall Heilman. “Organizations must protect what matters most – their sensitive data – and Spirion is step one for ensuring that protection.”
About Pieter De Leenheer
Pieter De Leenheer is an entrepreneur, venture capitalist, and computer scientist with 20 years of technical expertise building next-generation technologies that solve critical business problems at scale. He serves as CTO at 1upHealth, a health data platform company. Previously, De Leenheer was CTO at ZenOptics, an analytics catalog, and governance software company. He also founded Collibra, a data intelligence platform organization where he served as CSO for over 12 years. De Leenheer writes, teaches, and advises on computing and management aspects of data innovation, including for several national governments and the European Commission.
“Spirion’s innovative sensitive data governance platform together with its mission-driven leadership team make me bullish for the company’s future,” said Pieter De Leenheer. “I am looking forward to working alongside the rest of Spirion’s board to provide actionable insights and business perspectives that enterprises are looking for.”
Pieter De Leenheer holds Ph.D. and M.S. degrees in computer science from Vrije Universiteit and academic positions at Harvard Business School, Columbia University, and San Diego Supercomputer Center.
About Spirion
Spirion has relentlessly solved real data protection problems since 2006 with the accurate, contextual discovery of structured and unstructured data; purposeful classification; automated real-time risk remediation; and robust analytics and dashboards to give organizations greater visibility into their most at-risk data and assets. Spirion’s Privacy-Grade data protection software enables organizations to reduce risk exposure, gain visibility into their data footprint, and improve business efficiencies and decision-making while facilitating compliance with data protection laws and regulations.
For more information: https://www.spirion.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.